A merger could occur in the pharmaceutical industry: a company worth 400 billion dollars could be created.
The British AstraZeneca pharmaceutical giant is in talks with the American Bristol Myers Squibb, which could result in the creation of a company worth approximately 400 billion dollars, according to the Financial Times.
The British AstraZeneca pharmaceutical giant is in talks with the American Bristol Myers Squibb, which could result in the creation of a company worth around $400 billion, according to Financial Times.
